EUVIMEDEUVIMED entdecken
Open Access

Multilineage involvement in KMT2A ‐rearranged B acute lymphoblastic leukaemia: cell‐of‐origin, biology, and clinical implications

Umut Aypar iD, Deepika Dilip, Ramya Gadde, Dory M Londono, Ying Liu iD, Qi Gao, Mark B Geyer, Andriy Derkach, Yanming Zhang, Jacob L Glass, Mikhail Roshal, Wenbin Xiao

Histopathology · 2024

DOI: 10.1111/his.15203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2024. Verfasst von Umut Aypar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Cytogenetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Hauptthemen laut MEDLINE: Myeloid-Lymphoid Leukemia Protein, Histone-Lysine N-Methyltransferase. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Equinox Cycle for Survival, Cycle for Survival's Equinox Innovation Award in Rare Cancers, MSK Department of Pathology Internal Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

B lymphoblastic leukaemia/lymphoma (B‐ALL) is thought to originate from Pro/Pre‐B cells and the genetic aberrations largely reside in lymphoid‐committed cells. A recent study demonstrated that a proportion of paediatric B‐ALL patients have BCR :: ABL1 fusion in myeloid cells, suggesting a chronic myeloid leukaemia (CML)‐like biology in this peculiar subset of B‐ALL, although it is not entirely clear if the CD19‐negative precursor compartment is a source of the myeloid cells. Moreover, the observation has not yet been extended to other fusion‐driven B‐ALLs. Methods and results In this study we investigated a cohort of KMT2A ‐rearranged B‐ALL patients with a comparison to BCR :: ABL1 ‐rearranged B‐ALL by performing cell sorting via flow cytometry followed by FISH (fluorescence in situ hybridization) analysis on each of the sorted populations. In addition, RNA sequencing was performed on one of the sorted populations. These analyses showed that (1) multilineage involvement was present in 53% of BCR :: ABL1 and 36% of KMT2A ‐rearranged B‐ALL regardless of age, (2) multilineage involvement created pitfalls for residual disease monitoring, and (3) HSPC transcriptome signatures were upregulated in KMT2A ‐rearranged B‐ALL with multilineage involvement.

Conclusions

In summary, multilineage involvement is common in both BCR :: ABL1 ‐rearranged and KMT2A ‐rearranged B‐ALL, which should be taken into consideration when interpreting the disease burden during the clinical course.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloid-Lymphoid Leukemia ProteinHistone-Lysine N-MethyltransferaseHumansFemaleChildMaleChild, PreschoolAdolescentFusion Proteins, bcr-ablAdultIn Situ Hybridization, FluorescenceInfantGene RearrangementPrecursor B-Cell Lymphoblastic Leukemia-LymphomaYoung AdultMiddle AgedPrecursor Cell Lymphoblastic Leukemia-LymphomaAged

Substanzen

Myeloid-Lymphoid Leukemia ProteinKMT2A protein, humanHistone-Lysine N-MethyltransferaseFusion Proteins, bcr-abl

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Cytogenetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

ORCID-Profile: Umut Aypar, Ying Liu

Förderung

  • Equinox Cycle for Survival
  • Cycle for Survival's Equinox Innovation Award in Rare Cancers
  • MSK Department of Pathology Internal Research Fund
  • Alex's Lemonade Stand Foundation
  • Runx1 Research Program
  • NCI NIH HHS
  • MSK Leukaemia SPORE Career Enhancement Program,
  • National Cancer Institute

Zitieren

APA

Aypar, U., Dilip, D., Gadde, R., Londono, D. M., Liu, Y., Gao, Q., Geyer, M. B., Derkach, A., Zhang, Y., Glass, J. L., Roshal, M., & Xiao, W. (2024). Multilineage involvement in KMT2A ‐rearranged B acute lymphoblastic leukaemia: cell‐of‐origin, biology, and clinical implications. Histopathology. https://doi.org/10.1111/his.15203

Vancouver

Aypar U, Dilip D, Gadde R, Londono DM, Liu Y, Gao Q, et al. Multilineage involvement in KMT2A ‐rearranged B acute lymphoblastic leukaemia: cell‐of‐origin, biology, and clinical implications. Histopathology. 2024. doi:10.1111/his.15203

BibTeX
@article{Aypar2024,
  author = {Aypar, Umut and Dilip, Deepika and Gadde, Ramya and Londono, Dory M and Liu, Ying and Gao, Qi and Geyer, Mark B and Derkach, Andriy and Zhang, Yanming and Glass, Jacob L and Roshal, Mikhail and Xiao, Wenbin},
  title = {Multilineage involvement in KMT2A ‐rearranged B acute lymphoblastic leukaemia: cell‐of‐origin, biology, and clinical implications},
  journal = {Histopathology},
  year = {2024},
  doi = {10.1111/his.15203}
}
Kostenlos starten →